Innohep and Pentacarinat drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Innohep (tinzaparin sodium) and Pentacarinat (pentamidine isethionate). Common drug interactions include febrile neutropenia among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Innohep and Pentacarinat. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.
What is Innohep?
Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 9,243 Innohep users. Check the latest studies of Innohep.
What is Pentacarinat?
Pentacarinat has active ingredients of pentamidine isethionate. eHealthMe is studying from 1,546 Pentacarinat users. Check the latest studies of Pentacarinat.
44 people who take Innohep and Pentacarinat together, and have interactions are studied.

What are the common drug interactions of Innohep and Pentacarinat, by gender? *:
female:
- Febrile neutropenia (fever with reduced white blood cells)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hypovolaemia (a decreased volume of circulating blood in the body)
- Infection
- Intestinal perforation (complete penetration of the wall of the intestine)
- Pulmonary embolism (blockage of the main artery of the lung)
- Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
- Lymphocyte count decreased
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
- Pyrexia (fever)
male:
- Diarrhoea
- Haemorrhage (bleeding)
- C-reactive protein increased
- Duodenal ulcer
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
- Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Iron deficiency anaemia
- Leukocytosis (increased white blood cells)
What are the common drug interactions of Innohep and Pentacarinat, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Febrile neutropenia (fever with reduced white blood cells)
- Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
- Lymphocyte count decreased
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
- Pyrexia (fever)
- Neutropenia (an abnormally low number of neutrophils)
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Petit mal epilepsy (absence seizure)
- Duodenal ulcer
- Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
- Helicobacter gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium)
- Iron deficiency anaemia
- Spinal pain (pain in spine)
60+:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hypovolaemia (a decreased volume of circulating blood in the body)
- Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
- Loss of consciousness
- Mucosal inflammation (infection of mucous membrane)
- Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
- Arthralgia (joint pain)
- Cardiac failure
- Conjunctivitis (pink eye)
- Phlebitis (inflammation of the walls of a vein)
What are the existing conditions these people have? *
- Pain: 14 people, 31.82%
- Multiple Myeloma (cancer of the plasma cells): 12 people, 27.27%
- Anaemia (lack of blood): 10 people, 22.73%
- Hyperglycemia (high blood sugar): 10 people, 22.73%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 22.73%
- Lymphoma (cancer that begins in immune system cells): 10 people, 22.73%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 9 people, 20.45%
- High Blood Pressure: 9 people, 20.45%
- Abdominal Pain: 8 people, 18.18%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 15.91%
* Approximation only. Some reports may have incomplete information.
Do you take Innohep and Pentacarinat?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Innohep (9,243 reports)
- Pentacarinat (1,546 reports)
Browse all drug interactions of Innohep and Pentacarinat:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Innohep:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pentacarinat:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Innohep and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pentacarinat and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on tinzaparin sodium and pentamidine isethionate (the active ingredients of Innohep and Pentacarinat, respectively), and Innohep and Pentacarinat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cefepime Hydrochloride and Bortezomib - 5 seconds ago
- Drug interactions of Alcohol and Aripiprazole - 6 seconds ago
- Acute Graft Versus Host Disease and Diarrhea - 11 seconds ago
- Acute Graft Versus Host Disease and Stools - Watery - 11 seconds ago
- Could Lansoprazole cause Loss Of Libido? - 34 seconds ago
- Could Cellcept cause Local Swelling? - 36 seconds ago
- Could Eprex cause Depression Aggravated? - 40 seconds ago
- Could Triamterene And Hydrochlorothiazide cause Diarrhea? - 43 seconds ago
- Could Triamterene And Hydrochlorothiazide cause Stools - Watery? - 44 seconds ago
- Could Xanax cause Intervertebral Disc Degeneration? - 45 seconds ago